Clinical trial
Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
NCT00476944 · Gold, Herman K., MD, Other · Unknown status
Key facts
| NCT number | NCT00476944 |
|---|---|
| Title | Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI |
| Official title | Minimizing Post-Procedural Vascular Complications: Comparing Bivalirudin Versus Heparin/GP IIB/IIA in Patients Undergoing Percutaneous Coronary Intervention |
| Lead sponsor | Gold, Herman K., MD, Other |
| Collaborators | The Medicines Company Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Procedure |
| Interventions | Percutaneous Coronary Intervention (PCI) |
| Start date | Sep 1, 2006 |
| First posted | May 22, 2007 |
| Last update posted | May 22, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: